These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1560594)
1. [Analysis of coagulation factor XIII in Crohn's disease--establishment of a novel monoclonal anti-coagulation factor XIII antibody]. Ayabe T; Ashida T; Taruishi M; Saito Y; Murakami M; Obara T; Shibata Y; Namiki M Nihon Shokakibyo Gakkai Zasshi; 1992 Jan; 89(1):28-35. PubMed ID: 1560594 [TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease. Van Bodegraven AA; Tuynman HA; Schoorl M; Kruishoop AM; Bartels PC Scand J Gastroenterol; 1995 Jun; 30(6):580-5. PubMed ID: 7569767 [TBL] [Abstract][Full Text] [Related]
3. The usefulness of factor XIII levels in Crohn's disease. Cougard PA; Desjeux A; Vitton V; Baumstarck-Barrau K; Lesavre N; Grimaud JC J Crohns Colitis; 2012 Jul; 6(6):660-4. PubMed ID: 22398040 [TBL] [Abstract][Full Text] [Related]
4. Single step purification of platelet factor XIII using an immobilized factor XIII a-subunit monoclonal antibody. Lukacova D; Reed GL Thromb Haemost; 1993 Apr; 69(4):397-400. PubMed ID: 8497854 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody. Lukacova D; Matsueda GR; Haber E; Reed GL Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898 [TBL] [Abstract][Full Text] [Related]
6. Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Hayat M; Ariëns RA; Moayyedi P; Grant PJ; O'Mahony S Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):249-56. PubMed ID: 11953689 [TBL] [Abstract][Full Text] [Related]
7. Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease. Sjöber K; Eriksson S; Tenngart B; Roth EB; Leffler H; Stenberg P Autoimmunity; 2002 Aug; 35(5):357-64. PubMed ID: 12515290 [TBL] [Abstract][Full Text] [Related]
8. Significance of diminished factor XIII in Crohn's disease. Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457 [TBL] [Abstract][Full Text] [Related]
9. Hemostasis in Crohn's disease: low factor XIII levels in active disease. Wisén O; Gardlund B Scand J Gastroenterol; 1988 Oct; 23(8):961-6. PubMed ID: 3201134 [TBL] [Abstract][Full Text] [Related]
10. Deficiency of blood coagulation factor XIII in Crohn's disease. Oshitani N; Kitano A; Hara J; Suzuki N; Aoki T; Yasuda K; Watanabe Y; Obayashi M; Obata A; Nakamura S Am J Gastroenterol; 1995 Jul; 90(7):1116-8. PubMed ID: 7611208 [TBL] [Abstract][Full Text] [Related]
11. Generation and mechanism of action of a potent inhibitor of factor XIII function. Reed GL; Lukacova D Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006 [TBL] [Abstract][Full Text] [Related]
12. Combined use of factor XIII and endoscopic balloon dilatation in a patient with Crohn's disease, duodenal stenosis, and associated internal fistulas: the efficacy of coagulation factor XIII for the internal fistulas. Kamata N; Oshitani N; Suekane T; Sogawa M; Yamagami H; Watanabe K; Fujiwara Y; Arakawa T Am J Gastroenterol; 2008 Jun; 103(6):1573-4. PubMed ID: 18510623 [No Abstract] [Full Text] [Related]
13. Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. Katona E E; Ajzner E; Tóth K; Kárpáti L; Muszbek L J Immunol Methods; 2001 Dec; 258(1-2):127-35. PubMed ID: 11684129 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Crohn's disease fistulas with coagulation factor XIII. Oshitani N; Nakamura S; Matsumoto T; Kobayashi K; Kitano A Lancet; 1996 Jan; 347(8994):119-20. PubMed ID: 8538314 [No Abstract] [Full Text] [Related]
15. Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis. Seitz R; Leugner F; Katschinski M; Immel A; Kraus M; Egbring R; Göke B Digestion; 1994; 55(6):361-7. PubMed ID: 7705548 [TBL] [Abstract][Full Text] [Related]
16. Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis. Vrij AA; Rijken J; van Wersch JW; Stockbrügger RW Haemostasis; 1999; 29(6):326-35. PubMed ID: 10844406 [TBL] [Abstract][Full Text] [Related]
17. B protein of factor XIII: differentiation between free B and complexed B. Yorifuji H; Anderson K; Lynch GW; Van de Water L; McDonagh J Blood; 1988 Nov; 72(5):1645-50. PubMed ID: 3179443 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of coagulation factor XIII concentrate for reversing loss of tensile strength of rat intestinal anastomoses. Hasegawa H; Eguchi Y; Endoh K; Yoshida T; Okabe H; Tani T Eur Surg Res; 2004; 36(1):53-8. PubMed ID: 14730224 [TBL] [Abstract][Full Text] [Related]
19. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13. Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658 [TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q; Hogezand RA; Lamers CB; Verspaget HW Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]